FINNENCE ▪ THE WIRE FILE
THE WIRE · № 69044
News▲ Bullish
AbbVie's Telisotuzumab Adizutecan (Temab-A) Receives Two Breakthrough Therapy Designations From the U.S. FDA for CRC and NSCLC
KINDNews
DIRECTION▲ Bullish
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-07 12:30 UTC
LAST UPDATE2026-10-07 12:30 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Two FDA breakthrough designations de-risk and speed development of AbbVie's c-Met ADC in CRC and NSCLC.
AbbVie ADC gets two FDA designations
CATALYST TO WATCH
Trial data and regulatory milestones
MAIN RISK
Early-stage; approval not assured
FULL DISPATCH
Temab-A is an investigational, next-generation, c-Met-directed antibody-drug conjugate (ADC) with a novel topoisomerase 1 inhibitor (Top1i) being studied in advanced solid tumors including colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) These designations represent the...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Resonant Clinical Solutions and Haier Biomedical Introduce an Innovative Benchtop Centrifuge with a Natural Refrigerant2026-10-07 12:30 UTC
Resonant Clinical Solutions and Haier Biomedical Introduce an Innovative Benchtop Centrifuge with a Natural Refrigerant2026-10-07 12:30 UTC
→CORRELATIONshares Healthcare
Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda SC in Multiple European Markets2026-10-07 12:30 UTC
Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda SC in Multiple European Markets2026-10-07 12:30 UTC
→CORRELATIONshares Healthcare
International, cross-sector collaboration commits nearly $2 billion to build foundational data for AI models to predict and treat disease2026-10-07 13:00 UTC
International, cross-sector collaboration commits nearly $2 billion to build foundational data for AI models to predict and treat disease2026-10-07 13:00 UTC
→CORRELATIONshares Healthcare
HOPPR and CARPL.ai partner to give customers access to foundation models for building and fine-tuning radiology AI2026-10-07 13:01 UTC
HOPPR and CARPL.ai partner to give customers access to foundation models for building and fine-tuning radiology AI2026-10-07 13:01 UTC
→CORRELATIONshares Healthcare
Nurse Practitioner and Hello Dose Founder Bracha Banayan, RN, FNP, Releases "Why Are You Still Hungry?" -- A Patient Guide to GLP-1 Medications and Lasting Habit Change2026-10-07 13:02 UTC
Nurse Practitioner and Hello Dose Founder Bracha Banayan, RN, FNP, Releases "Why Are You Still Hungry?" -- A Patient Guide to GLP-1 Medications and Lasting Habit Change2026-10-07 13:02 UTC
→CORRELATIONshares Healthcare
SEC-FDA agreement: What life sciences leaders should know2026-10-07 13:11 UTC
SEC-FDA agreement: What life sciences leaders should know2026-10-07 13:11 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.